Can-Fite BioPharma (CANF) Net Shares Issued and Repurchased (2017 - 2025)

Can-Fite BioPharma (CANF) has 8 years of Net Shares Issued and Repurchased data on file, last reported at $8000.0 in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 99.98% year-over-year to $8000.0; the trailing twelve-month figure through Dec 2025 stood at $8000.0 (down 99.98% YoY), and the FY2025 full-year result was $8000.0, down 99.98% from the prior year.
• Net Shares Issued and Repurchased was $8000.0 for Q4 2025 at Can-Fite BioPharma, down from $50.0 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $55.5 million in Q4 2023 to a low of $8000.0 in Q4 2025.
• A 5-year average of $24.3 million and a median of $8.8 million in 2022 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased jumped 534.29% in 2023 and plunged 99.98% in 2025, its largest moves.
• Can-Fite BioPharma's Net Shares Issued and Repurchased stood at $7.1 million in 2021, then gained by 23.24% to $8.8 million in 2022, then jumped by 534.29% to $55.5 million in 2023, then slipped by 9.91% to $50.0 million in 2024, then plunged by 99.98% to $8000.0 in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $8000.0 in Q4 2025, $50.0 million in Q4 2024, and $55.5 million in Q4 2023.